We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Provexis Plc | LSE:PXS | London | Ordinary Share | GB00B0923P27 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.675 | 0.60 | 0.75 | - | 0.00 | 11:02:46 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Food Preparations, Nec | 802k | -586k | -0.0003 | -22.33 | 14.97M |
Date | Subject | Author | Discuss |
---|---|---|---|
13/11/2021 09:43 | By-health hitting new highs in online selling | winner31 | |
12/11/2021 14:45 | winner - what have they learned exactly?If they have we don't know because no one bothered to ask them.By all accounts the bod got yet another free pass this year. | redprince | |
12/11/2021 13:56 | Maybe they have learned from that mistake By- health will have Exclusive rights to approx 1.5 billion people . ‘ The Agreement, which will take full effect from 1 January 2023, gives By-Health exclusive supply and distribution rights to commercialise the Company's lead Fruitflow heart-health technology in Mainland China, Hong Kong, Macau, Taiwan and Australia (the 'Territories'). | winner31 | |
12/11/2021 13:45 | The fact that DSM did not attend the agm speaks volumes imo.They have completely failed to do anything meaningful with FF.I am certain that refusal to offer exclusivity to potential customers has played a key role. To think that arouund 15 years ago CC and Unilever were looking at this and exclusivity cost us at least one of them... I am also certain that the pi's who attended the meeting did not bother to ask...too busy listening to the bs from the bod after being fed a soften em up rns. | redprince | |
12/11/2021 11:45 | Will this break out of range soon? PVS seems ok for now! Meanwhile people are accumulating 81% been held at June reporting data/date... remarkably more popular than the share price is saying: | davemarn | |
12/11/2021 11:43 | This share is dead in the water. | rich1952 | |
12/11/2021 11:16 | Someone’s accumulating , another 1 million buy | winner31 | |
08/11/2021 12:12 | As of the 1st of January 2023, and the end of the alliance agreement with DSM as we know it, By-Health will be able to sell Fruitflow and Fruitflow based functional food and dietary supplement finished products to Hong Kong, Macau, Taiwan and Australia providing the products are authorised by the relevant Government authorities. They will also be able to sell Fruitflow in China to manufacturers that don't have blue cap on their products. What that means in sales from 2023, who knows, but i doubt By-Health will be in a position to sell their own fruitflow products within China until they have approvals. Thats how I understand it anyway. | gix er | |
08/11/2021 10:33 | Ahh well the above post by gixer explains exactly why we should take the possible timeframe as outlined in the last rns with a bucket of salt. Some folk just hear what they want to hear - the bod are laughing at you and their salaries are guaranteed for yet another year. | redprince | |
08/11/2021 07:19 | Hi Huntergls, Yes the clues are in the RNS but they clues tell me that Blue Cap has not been applied for, instead, By-Health are now working towards changing the permitted health function claims to allow a better fit for Fruitflow. Long term I believe this is the best outcome for Fruitflow but we now have no Idea how long it will be before By-Health will be in a position to sell Fruitflow based products in China if they are only starting submissions in 2022. | gix er | |
07/11/2021 20:53 | Kievsky - we have met before and you are a decent bloke from what i recall however every year you fall for the same old jam tomorrow lines that they spin you - you have been saying TTNY for around 4 or 5 years now. You need to take the rns's with a pinch of salt as they have proven to be subject to change in the past. Aimho. | redprince | |
07/11/2021 19:04 | Hi Gixer. Would like to have a chat by phone. All what I said was IMO? Clues are always in the RNS | huntergls | |
07/11/2021 13:41 | Huntergls, A couple of questions if I may? 1. Has/did the company (PXS) confirm that By-Health has applied for Blue Cap? 2. What did the company say to lead you to believe that "late 2022 early 2023 is key"? Thanks. | gix er | |
07/11/2021 09:04 | Huntergis - glad you were able to attend and i would have liked to have refreshed some old acquaintances however after far too many years of undeserved largesse on our directors and shareholder apathy i simply dont see the point in attending now. You have said the same thing year after year and this year you were fed an rns to soften shareholders up before the meeting. What you cannot deny is that the bod have taken millions in payment for running a company that has less turnover (and no profit) than a kebab shop on Tottenhan High Road.That has cost us all plenty. The rns has given some clarity as to a potential timeline but we were originally told 2017 so i take the new timeline with a bucket of salt. The only bit of new good news is that we are to supply By-Health directly with FF which by cutting out DSM should improve our share of the profit if IF can negotiate a deal on favourable terms. Noone has managed to ask hpw DSM use exclusivity and under what circumstances it gets dropped - that is what almost certainly cost us the MM Sirco shot deal. I am quite sure noone bothered to ask it (i did previously) no doubt because you were all taken in by the rns. Aimho. | redprince | |
07/11/2021 08:16 | Great day in the big smoke Thursday. Nice RNS surprise before the meeting. Both DB and IF were in fine fettle. No one there from DSM. Good attendance from old and new investors. Few beers after with a few of them. All we need now is BH to get blue cap and we're laughing. Seems late 2022 early 2023 is key. Let's see how DSM react in the new deal discussions. I will definitely topping up over the 12 months on any dips S | huntergls | |
04/11/2021 15:12 | Bareknee - fair enough i had not seen that as i had only skimmed it.Good point. | redprince | |
04/11/2021 13:35 | Red prince The new thing in the RNS is that we won't be sharing profits with DSM on FF sales to By-Health. Assuming we can manage the interface between the supply chain and By-Health to increase our effective cut, then that'll feed through to our bottom line. So, if for example, our share of Y1 profits from sales to By-Health via DSM might have been 500k ( not an unreasonable assumption ? ), then we might end up with a net figure between 650 and 750k. Plainly there's a lot of guesswork in that, and there's still a lot of jam tomorrow in the story, but it looks pretty positive to me. The possibility of going down the drug route in China could, long-term, be a real game changer, but would need oodles of cash to turn it into a reality | bareknee | |
04/11/2021 13:02 | I take todays rns with a very large dose of salt.We have heard this all before and there is nothing really new in there apart from a timescale which going on past announcements means nothing. It smacks of trying to avoid taking any flak from pi's at the agm to be honest. Okay its good that By-Health are still on board but i cant see anything new in the announcement. | redprince | |
04/11/2021 11:25 | Looks like some good news after a long time waiting. | twodegrees | |
27/10/2021 06:51 | hxxps://biogrow.com. another outlet, strong presence in a big market. | senor_sensible | |
16/10/2021 11:45 | With the renewal date on our partnership with DSM approaching it would be good for agm attendees to ask some pertinent questions as to why after 10 years we have not had a major customer and to ask DSM to explain under what circumstances do they consider granting exclusivity to a potential customer. I did ask these before but frankly the continual cut n paste wore thin years ago. We all know that MM cancelled a much anticipated shot version and lack of exclusivity was one of if not the major reason - and nowt came in its place. We cant just sit back and put all our hopes on the Chinese. | redprince | |
13/10/2021 23:15 | Kin 'ell NoR, the lack of understanding displayed about COVID vaccination in your post is staggering. Yes, some people will have a bad reaction to being jabbed, and some of those may actually be fatal, but you're taking information massively out of context. Your paranoia ( for that's what it is ),on this and other subjects is concerning. It seems you're looking for simple solutions to explain things you, and most of us, can't understand. You'd be better off trying to look for positives in life, such as why infections in the at risk population are running at about 1%, much the same as they were in previous peaks, but hospitalisations and deaths are much, much lower. One major thing has changed, and that's jabs going into arms BB | bareknee | |
12/10/2021 21:56 | Clotting caused by the jabbers not Aspirating , of course the Gov cant be touched for any of these blunders due to the emergency measures regs. Pfizer staff filmed saying the vax doesn't offer any protection recently , hardly surprising seeing the stats .It is a mass cull folks. | nestoframpers |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions